Iofina Doubles Down on Iodine — Just as Its Input Costs Start Crawling Back Up
A record half, a first-ever two-plant build, and a quiet cost warning that ties a tiny Oklahoma producer to a global fuel story
IOF.L · Earnings Call · 2026-09-24
A Record Print Hiding Two Opposing Signals
Iofina plc, the roughly $90 million-market-cap iodine producer, reported H1 2026 on 24 September. The headline numbers are the best the company has posted: revenue of $31.3 million, gross profit up from $6.3 million to $10.2 million, and EBITDA that doubled. As CFO Malcolm Lewin framed it, “we wind up with $6.6 million, which is double the 2025 number of $3.3 million” — Malcolm Lewin, CFO · 2026-09-24. Net cash swung to positive $7.2 million from a $1.8 million net-debt position a year earlier. But the more interesting content of this call is not the backward-looking print — it is a pair of forward signals pulling in opposite directions: a genuine step-up in build ambition, and the first new cost headwind in a year.The Pipeline Finally Steps Up a Gear
Iofina's model rests on Iofina Resources, the division that strips iodine out of waste brine water at oil-and-gas partner sites across Oklahoma and now the Permian. Through the last four years it built one plant a year; that cadence is now breaking upward. IO#12, the largest facility it has ever built, takes in 50,000 barrels of water per day in the Permian Basin and is weeks from first water. Then, in a genuine first, the company announced IO#13 and IO#14 together in Oklahoma — building two at once for the first time, aiming at what management calls “six plants in five years” — Tom Becker, CEO · 2026-09-24. The exploratory future sites pipeline — with a partner handling 2.5 million barrels of water a day — is the real option embedded here. The scale matters. Management reaffirmed its "pathway to 2000" run-rate target and, with IO#12 online, expects to exceed a 1,000 metric-ton capacity from a base of roughly 500. That is a doubling of output against a market management believes grows ~3% a year — deliberately gunning at a fraction of new demand without tipping the market's supply-demand balance.The Cost Warning
Here is the part a headline reader may miss. After a first half in which average production cost per kilo fell 15% — volume up 29% against direct costs up just 10% — CEO Tom Becker flagged that the tailwind is reversing.That is a striking confluence. Iofina is a domestic, Oklahoma/Permian iodine producer with essentially no operational exposure to the Middle East or to shipping — yet its input costs are now being set by exactly the forces that dominated high fuel costs and Middle East impacted in the broader market's Q2 keyword set. A cost benefit driven partly by luck (a surprisingly mild Oklahoma winter that avoided the icing and pump downtime of H1 2025) is being replaced by a headwind driven by global commodities. The offset is that Iofina contracts its major chemicals precisely to damp this kind of move — a lever worth watching next quarter. There is a second, quieter macro tell from Washington. Lewin credited the OBBBA bill — the same Big Beautiful legislation that ricocheted through the global keyword set last year — with enabling near-100% write-offs on capital expenditure, pushing deferred tax to $5 million and supporting cash flow through the build-out. In one line item, this minnow is a direct beneficiary of the tax policy the rest of the tape is still arguing about.we have seen a little bit of creep of these chemical costs moving into the second half of the year, and that is mainly due to increased raw material costs, mainly influenced by fuel cost increases and some other things that are manufactured in the Middle East.
Same Questions, Same Vague Answers
Not everything changed. The Q&A recycled three durable investor concerns. On the maiden dividend, Becker was unmoved: “we keep reinvesting the cash generation into new plants and other CapEx things” — Tom Becker, CEO · 2026-09-24. On IO#13/14 tonnage, the answer remained — as in the prior quarter — vague; back in May he had said plainly “We don't have an answer for that for the IO#13 plant” — Thomas Becker, CEO · 2026-05-19. And then the one that actually got resolved:Becker's answer — that the sales team re-surveyed the market and can now absorb two plants' output — is arguably the single most important de-risking in the call. The company says it already has sales in hand for all projected 2026 open-market crystalline iodine.a few months ago at the AGM, I said building two plants would cause sales issues, coping with the increase of production. What has changed?